SCHEMBL3457641

SCHEMBL3457641

CCN1C=CN(Cc2ccccc2)C1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.42
TP53 P04637 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
ELANE P08246 3/20 0.37
LMNA P02545 2/20 0.37
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MAPT P10636 1/20 0.37
PRKCA P17252 1/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
F2 P00734 1/20 0.36
PLG P00747 1/20 0.36
CTSG P08311 1/20 0.36
CMA1 P23946 1/20 0.36
CTRC Q99895 1/20 0.36
MC4R P32245 1/20 0.36
CALM1 P0DP23 1/20 0.36
CYP19A1 P11511 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1078734 0.92 ACHE (0.47) ACHETP53SIGMAR1ELANELMNA
Hydrochloric Acid SCHEMBL18789343 0.90 ACHE (0.46) ACHESIGMAR1ELANELMNAALDH1A1
SCHEMBL5305203 0.85 ACHE (0.40) ACHETP53SIGMAR1ELANELMNA
SCHEMBL1044086 0.83 LMNA (0.55) ACHETP53LMNAALDH1A1NPSR1
SCHEMBL5307350 0.82 PDE2A (0.42) SIGMAR1ALDH1A1
SCHEMBL5289001 0.81 PDE2A (0.43) LMNAALDH1A1CYP19A1MEN1KMT2A
SCHEMBL28135984 0.81 ACHE (0.42) ACHESIGMAR1ELANELMNAALDH1A1
SCHEMBL1832291 0.81 ACHE (0.42) ACHESIGMAR1ELANELMNAALDH1A1
SCHEMBL5813625 0.80 PDE2A (0.44) LMNAALDH1A1CYP19A1MEN1KMT2A
SCHEMBL1895652 0.80 PDE2A (0.44) LMNAALDH1A1CYP19A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100321863-A1 ACTIVATED CARBON AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-23 US disclosed
US-7785495-B2 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-31 US disclosed
CN-101535179-A Activated carbon and method for producing the same SUMITOMO CHEMICAL CO (JP) 2009-09-16 CN disclosed
EP-2093191-A1 ACTIVATED CARBON AND METHOD FOR PRODUCING THE SAME Sumitomo Chemical Company, Limited (JP) 2009-08-26 EP disclosed
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-23 US disclosed
CN-101184691-A Electric double layer capacitor SUMITOMO CHEMICAL CO (JP) 2008-05-21 CN disclosed
EP-1905740-A1 ELECTRIC DOUBLE LAYER CAPACITOR Sumitomo Chemical Company, Limited (JP) 2008-04-02 EP disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 CBR1, CYP24A1, CALU ACHE 1559/4885TP53 2910/4885SIGMAR1 689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.